Literature DB >> 7863032

MR imaging of minamata disease: qualitative and quantitative analysis.

Y Korogi1, M Takahashi, M Sumi, T Hirai, T Okuda, J Shinzato, T Okajima.   

Abstract

Minamata disease (MD), a result of methylmercury poisoning, is a neurological illness caused by ingestion of contaminated seafood. We evaluated MR findings of patients with MD qualitatively and quantitatively. Magnetic resonance imaging at 1.5 Tesla was performed in seven patients with MD and in eight control subjects. All of our patients showed typical neurological findings like sensory disturbance, constriction of the visual fields, and ataxia. In the quantitative image analysis, inferior and middle parts of the cerebellar vermis and cerebellar hemispheres were significantly atrophic in comparison with the normal controls. There were no significant differences in measurements of the basis pontis, middle cerebellar peduncles, corpus callosum, or cerebral hemispheres between MD and the normal controls. The calcarine sulci and central sulci were significantly dilated, reflecting atrophy of the visual cortex and postcentral cortex, respectively. The lesions located in the calcarine area, cerebellum, and postcentral gyri were related to three characteristic manifestations of this disease, constriction of the visual fields, ataxia, and sensory disturbance, respectively. MR imaging has proved to be useful in evaluating the CNS abnormalities of methylmercury poisoning.

Entities:  

Mesh:

Year:  1994        PMID: 7863032

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  2 in total

1.  Hyperintense lesions in brain MRI after exposure to a mercuric chloride-containing skin whitening cream.

Authors:  Marcus R Benz; Seung-Hee Lee; Lars Kellner; Christoph Döhlemann; Steffen Berweck
Journal:  Eur J Pediatr       Date:  2010-10-30       Impact factor: 3.183

2.  Dementia, epilepsy and polyneuropathy in a mercury-exposed patient: investigation, identification of an obscure source and treatment.

Authors:  Tobias Zellner; Nicolas Zellner; Norbert Felgenhauer; Florian Eyer
Journal:  BMJ Case Rep       Date:  2016-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.